版本:
中国

BRIEF-Cerecor announces completion of enrollment in Phase 2 clinical trial

Sept 21 Cerecor Inc :

* Announces completion of enrollment in Phase 2 Clinical Trial with CERC-301 as an oral, adjunctive treatment of major depressive disorder

* Top-Line data now expected in November 2016 Source text for Eikon: Further company coverage: [CERC.O ]

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐